Literature DB >> 10988337

The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing.

J Cartmell1, J A Monn, D D Schoepp.   

Abstract

We have previously reported that the specific group II metabotropic glutamate receptor agonist LY379268 inhibited phencyclidine (PCP)-induced motor activations in rats, but had mixed effects on behaviors produced by amphetamine. Here, LY379268 (1 mg/kg subcutaneous (s.c.)) attenuated amphetamine-induced ambulations and rearing but did not alter amphetamine-evoked fine motor movements. Consistent with a mechanism involving mGlu(2/3) receptors, the inhibitory actions of LY379268 on ambulations and rearing were reversed by LY341495, a mGlu(2/3) receptor antagonist. These data further suggest antipsychotic actions of mGlu(2/3) receptor agonists with a low propensity for extra-pyramidal side effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988337     DOI: 10.1016/s0014-2999(00)00423-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  30 in total

Review 1.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.

Authors:  Dhaval Nanavati; Daniel R Austin; Lisa A Catapano; David A Luckenbaugh; Ayse Dosemeci; Husseini K Manji; Guang Chen; Sanford P Markey
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

Review 3.  Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Authors:  Meng-Lin Li; Xi-Quan Hu; Feng Li; Wen-Jun Gao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

4.  Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).

Authors:  Michael P Johnson; David Barda; Thomas C Britton; Renee Emkey; William J Hornback; G Erik Jagdmann; David L McKinzie; Eric S Nisenbaum; Joseph P Tizzano; Darryle D Schoepp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

5.  Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.

Authors:  Jason M Uslaner; Sean M Smith; Sarah L Huszar; Rashida Pachmerhiwala; Richard M Hinchliffe; Joshua D Vardigan; Pete H Hutson
Journal:  Psychopharmacology (Berl)       Date:  2009-08-26       Impact factor: 4.530

6.  Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence.

Authors:  Peter R Kufahl; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

7.  Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

Authors:  Andrea M Bradford; Kevin M Savage; Declan N C Jones; Mikhail Kalinichev
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

8.  Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.

Authors:  Yukio Ago; Ryota Araki; Koji Yano; Naoki Hiramatsu; Toshiyuki Kawasaki; Shigeyuki Chaki; Atsuro Nakazato; Hirotaka Onoe; Hitoshi Hashimoto; Akemichi Baba; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

9.  Subunit selective decrease of AMPA and metabotropic glutamate receptor mRNA expression in rat brain by systemic administration of the NMDA receptor blocker MK-801.

Authors:  Markus Storvik; Anni-Maija Lindén; Merja Lakso; Garry Wong
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

10.  Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys.

Authors:  Rayna M Bauzo; Heather L Kimmel; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2009-08-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.